BlackRock Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.91M | Sell |
75,196
-12,519
| -14% | -$484K | ﹤0.01% | 1951 |
|
|
2016
Q3 | $4.44M | Buy |
87,715
+187
| +0.2% | +$9.47K | 0.01% | 1566 |
|
|
2016
Q2 | $3.98M | Sell |
87,528
-261,566
| -75% | -$11.9M | 0.01% | 1601 |
|
|
2016
Q1 | $13.8M | Buy |
349,094
+6,565
| +2% | +$260K | 0.02% | 742 |
|
|
2015
Q4 | $19.4M | Buy |
342,529
+16,517
| +5% | +$934K | 0.02% | 589 |
|
|
2015
Q3 | $13M | Sell |
326,012
-9,504
| -3% | -$378K | 0.02% | 769 |
|
|
2015
Q2 | $16M | Buy |
335,516
+60,600
| +22% | +$2.89M | 0.02% | 699 |
|
|
2015
Q1 | $10.9M | Buy |
274,916
+16,862
| +7% | +$670K | 0.01% | 907 |
|
|
2014
Q4 | $5.77M | Sell |
258,054
-4,526
| -2% | -$101K | 0.01% | 1264 |
|
|
2014
Q3 | $4.12M | Sell |
262,580
-245
| -0.1% | -$3.84K | 0.01% | 1473 |
|
|
2014
Q2 | $3.9M | Buy |
262,825
+55,078
| +27% | +$817K | 0.01% | 1569 |
|
|
2014
Q1 | $3.35M | Buy |
207,747
+24,444
| +13% | +$394K | ﹤0.01% | 1670 |
|
|
2013
Q4 | $1.71M | Sell |
183,303
-5,693
| -3% | -$53.2K | ﹤0.01% | 2122 |
|
|
2013
Q3 | $2.14M | Buy |
188,996
+11,251
| +6% | +$127K | ﹤0.01% | 1897 |
|
|
2013
Q2 | $2.38M | Buy |
+177,745
| New | +$2.38M | ﹤0.01% | 1729 |
|